Shares of DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) have been given an average rating of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is C$18.07.
Several equities analysts have commented on DHT.UN shares. Royal Bank Of Canada increased their price target on shares of DRI Healthcare Trust from C$17.00 to C$18.00 and gave the company an “outperform” rating in a research note on Thursday, May 22nd. CIBC increased their price target on shares of DRI Healthcare Trust from C$16.00 to C$17.00 and gave the company an “outperform” rating in a research note on Thursday, May 22nd. Finally, National Bankshares increased their price target on shares of DRI Healthcare Trust from C$18.00 to C$18.50 and gave the company an “outperform” rating in a research note on Thursday, May 22nd.
View Our Latest Research Report on DRI Healthcare Trust
DRI Healthcare Trust Trading Down 2.6%
DRI Healthcare Trust Company Profile
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.
Read More
- Five stocks we like better than DRI Healthcare Trust
- Compound Interest and Why It Matters When Investing
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- Ride Out The Recession With These Dividend Kings
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- 3 Warren Buffett Stocks to Buy Now
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.